Mohammad Ramezani Selected Research

Nucleolin

10/2023	Dual-targeted delivery system using hollow silica nanoparticles with H+-triggered bubble generating characteristic coated with hyaluronic acid and AS1411 for cancer therapy.
11/2022	AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer.
7/2022	Synthesis of manganese-incorporated polycaplactone-poly (glyceryl methacrylate) theranostic smart hybrid polymersomes for efficient colon adenocarcinoma treatment.
1/2021	Fabrication of versatile targeted lipopolymersomes for improved camptothecin efficacy against colon adenocarcinoma in vitro and in vivo.
11/2020	Co-delivery of doxorubicin and aptamer against Forkhead box M1 using chitosan-gold nanoparticles coated with nucleolin aptamer for synergistic treatment of cancer cells.
11/2020	Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo.
7/2020	Therapeutic applications of AS1411 aptamer, an update review.
1/2019	High affinity of AS1411 toward copper; its application in a sensitive aptasensor for copper detection.
10/2018	Fabrication of acetylated carboxymethylcellulose coated hollow mesoporous silica hybrid nanoparticles for nucleolin targeted delivery to colon adenocarcinoma.
6/2018	Targeted delivery of melittin to cancer cells by AS1411 anti-nucleolin aptamer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohammad Ramezani Research Topics

Disease

127	Neoplasms (Cancer) 03/2024 - 02/2011
29	Breast Neoplasms (Breast Cancer) 02/2024 - 05/2015
19	Colonic Neoplasms (Colon Cancer) 01/2023 - 05/2010
12	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 05/2015
10	Carcinoma (Carcinomatosis) 03/2023 - 01/2016
10	Adenocarcinoma 07/2022 - 10/2012
8	Cardiotoxicity 10/2017 - 10/2005
7	Neuroblastoma 02/2017 - 09/2009
6	Inflammation (Inflammations) 04/2024 - 03/2002
5	Leukemia 03/2024 - 02/2011
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017 - 02/2011
4	Thrombosis (Thrombus) 03/2024 - 01/2016
4	Lung Neoplasms (Lung Cancer) 11/2017 - 10/2012
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2014 - 11/2011
3	Neoplasm Metastasis (Metastasis) 07/2022 - 07/2018
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 07/2015
3	Necrosis 11/2020 - 09/2005
3	Body Weight (Weight, Body) 12/2018 - 07/2015
3	Atherosclerosis 01/2016 - 11/2011
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2024 - 12/2020
2	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2022 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 08/2022 - 01/2020
2	Inborn Genetic Diseases (Disease, Hereditary) 02/2021 - 03/2016
2	Infections 06/2020 - 01/2007

Drug/Important Bio-Agent (IBA)

35	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2024 - 10/2005
31	AGRO 100IBA 03/2024 - 09/2014
19	APTIBA 03/2024 - 10/2013
19	NucleolinIBA 10/2023 - 09/2014
18	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 09/2009
14	Proteins (Proteins, Gene)FDA Link 07/2023 - 11/2011
14	Biomarkers (Surrogate Marker)IBA 08/2022 - 02/2011
12	LigandsIBA 11/2022 - 01/2012
10	GoldIBA 03/2024 - 07/2015
10	Epirubicin (Ellence)FDA LinkGeneric 12/2023 - 09/2013
10	Peptides (Polypeptides)IBA 08/2022 - 10/2015
9	PolyethyleneimineIBA 03/2024 - 05/2015
9	PolymersIBA 03/2024 - 01/2016
9	Small Interfering RNA (siRNA)IBA 07/2023 - 05/2015
8	Adenosine Triphosphate (ATP)IBA 01/2023 - 05/2016
8	CamptothecinIBA 01/2022 - 03/2017
7	Silicon Dioxide (Silica)FDA LinkGeneric 10/2023 - 06/2017
7	Nucleotide AptamersIBA 03/2023 - 07/2015
6	MicellesIBA 01/2022 - 01/2018
6	Epithelial Cell Adhesion MoleculeIBA 12/2021 - 02/2015
6	Polylactic Acid-Polyglycolic Acid CopolymerIBA 03/2019 - 01/2016
6	Dendrimers (Dendrons)IBA 10/2018 - 04/2016
5	Folic Acid (Vitamin M)FDA LinkGeneric 03/2024 - 03/2016
5	Hyaluronic Acid (Hyaluronan)IBA 03/2024 - 12/2019
5	5TR1 aptamerIBA 12/2023 - 04/2016
5	Nucleic AcidsIBA 08/2022 - 06/2013
4	Antineoplastic Agents (Antineoplastics)IBA 02/2024 - 10/2017
4	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2022 - 11/2020
4	ChitosanIBA 11/2020 - 01/2017
4	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 09/2020 - 11/2015
4	Carbon Nanotubes (Carbon Nanotube)IBA 01/2017 - 02/2011
4	Pentoxifylline (Trental)FDA LinkGeneric 01/2014 - 11/2011
3	ResveratrolIBA 04/2024 - 05/2017
3	Mucin-1 (CA 15-3 Antigen)IBA 12/2023 - 04/2019
3	VaccinesIBA 07/2023 - 12/2015
3	Dextrans (Dextran)FDA Link 01/2022 - 10/2017
3	SolventsIBA 12/2021 - 04/2017
3	Docetaxel (Taxotere)FDA Link 08/2021 - 11/2016
3	monomethoxypolyethyleneglycol- polylactide block copolymerIBA 12/2020 - 10/2017
3	EnzymesIBA 09/2020 - 09/2017
3	AntigensIBA 01/2020 - 11/2016
3	Cisplatin (Platino)FDA LinkGeneric 04/2019 - 09/2005
3	polyethylene glycol-poly(lactide-co-glycolide)IBA 10/2017 - 02/2015
3	LuciferasesIBA 02/2017 - 09/2009
3	Daunorubicin (Cerubidine)FDA LinkGeneric 04/2016 - 02/2011
2	Acetic Acid (Vinegar)FDA LinkGeneric 04/2024 - 03/2002
2	Thrombin FDA Link 03/2024 - 01/2020
2	CytokinesIBA 09/2023 - 01/2020
2	Interleukin-18 (Interleukin 18)IBA 09/2023 - 01/2014
2	Cancer VaccinesIBA 09/2023 - 11/2017
2	EstersIBA 09/2023 - 03/2019
2	Messenger RNA (mRNA)IBA 07/2023 - 02/2014
2	OligonucleotidesIBA 07/2023 - 03/2019
2	Therapeutic UsesIBA 07/2023 - 03/2023
2	SynucleinsIBA 11/2022 - 01/2019
2	Cruciform DNA (Holliday Junctions)IBA 08/2022 - 11/2018
2	SurvivinIBA 01/2022 - 11/2020
2	Contrast MediaIBA 01/2022 - 01/2021
2	SMAC peptideIBA 01/2022 - 09/2020
2	Eosine Yellowish-(YS) (Eosin)IBA 12/2020 - 11/2020
2	Hematoxylin (Haematoxylon)IBA 12/2020 - 11/2020
2	poly(lactide) (polylactic acid)IBA 09/2020 - 01/2019
2	A-Form DNA (A-DNA)IBA 08/2020 - 09/2014
2	galbanic acidIBA 01/2020 - 01/2019
2	AcidsIBA 01/2020 - 11/2017
2	PAMAM StarburstIBA 12/2019 - 03/2017
2	Melitten (Melittin)IBA 04/2019 - 06/2018

Therapy/Procedure

59	Therapeutics 03/2024 - 10/2013
18	Precision Medicine 03/2024 - 03/2016
17	Drug Therapy (Chemotherapy) 03/2024 - 10/2013
5	Intravenous Injections 06/2023 - 07/2015
4	Immunotherapy 02/2024 - 12/2015
3	Quantum Dots (Quantum Dot) 03/2020 - 09/2014
3	Injections 10/2019 - 04/2016